Ji Wan Qiu
Directeur Général chez QYUNS THERAPEUTICS CO., LTD.
Fortune : 206 M $ au 30/04/2024
Profil
Ji Wan Qiu is the Chairman & Chief Executive Officer of Qyuns Therapeutics Co., Ltd., a company founded in 2015.
He was also the General Manager of Jiangsu T-Mab Biopharma Co. Ltd., a company founded in 2005.
Mr. Qiu previously held the position of Director-Research Institute at Hangzhou Jiuyuan Gene Engineering Co. Ltd.
from 1993 to 2004.
He was also the Deputy General Manager at Epitomics (Hangzhou) Biotechnology Co., Ltd.
from 2004 to 2005.
Additionally, Mr. Qiu served as the General Manager of Jiangsu Cellularforce Biotechnology Co. Ltd.
from 2018 to 2023.
Mr. Qiu obtained an MBA from Zhejiang University in 2005 and an undergraduate degree from Fudan University in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2024 | 70 550 000 ( 34,46% ) | 206 M $ | 30/04/2024 |
Postes actifs de Ji Wan Qiu
| Sociétés | Poste | Début |
|---|---|---|
| QYUNS THERAPEUTICS CO., LTD. | Directeur Général | 05/06/2015 |
Anciens postes connus de Ji Wan Qiu
| Sociétés | Poste | Fin |
|---|---|---|
| Jiangsu Cellularforce Biotechnology Co. Ltd. | Directeur Général | 01/03/2023 |
| Jiangsu T-Mab Biopharma Co. Ltd. | Directeur Général | 01/01/2015 |
Epitomics (Hangzhou) Biotechnology Co., Ltd.
 Epitomics (Hangzhou) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Epitomics (Hangzhou) Biotechnology Co., Ltd. is a private company based in Hangzhou, China that manufactures monoclonal antibody drugs. | Corporate Officer/Principal | 01/06/2005 |
Hangzhou Jiuyuan Gene Engineering Co. Ltd.
 Hangzhou Jiuyuan Gene Engineering Co. Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China. | Corporate Officer/Principal | 01/01/2004 |
Formation de Ji Wan Qiu
| Zhejiang University | Masters Business Admin |
| Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QYUNS THERAPEUTICS CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Hangzhou Jiuyuan Gene Engineering Co. Ltd.
Hangzhou Jiuyuan Gene Engineering Co. Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China. | Health Technology |
Epitomics (Hangzhou) Biotechnology Co., Ltd.
Epitomics (Hangzhou) Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Epitomics (Hangzhou) Biotechnology Co., Ltd. is a private company based in Hangzhou, China that manufactures monoclonal antibody drugs. | Health Technology |
| Jiangsu T-Mab Biopharma Co. Ltd. | |
| Jiangsu Cellularforce Biotechnology Co. Ltd. |
